Hannover Rück, DE0008402215

Hannover Rück stock gets a November reporting date for Q3 2026

Published on 10/05/2026 at 16:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hannover Rück targets at least EUR 2.7 billion in 2026 net income, while its Q2 net income reached EUR 695.3 million. The next report is due November 9, 2026.

Editorial-Foto eines Börsenhandelsraums mit Bildschirmen, DAX-Kürzel und Finanzcharts
Hannover Rück SE (DE0008402215) ist im DAX gelistet, illustriert durch eine belebte Handelsraum-Szene mit Kurscharts, Illustration mit AI erstellt.

Hannover Rück (ISIN DE0008402215) was trading at EUR 254.20 on Xetra on October 5, 2026, down 0.31 percent from the previous close. The company set November 9, 2026, as the publication date for its quarterly statement covering the period to September 30, according to EQS News on October 5, 2026.

November date sets next test

The November publication will give investors a fresh view of claims development, underwriting conditions and progress toward the full-year target. The company targets consolidated net income of at least EUR 2.7 billion for 2026, provided major-loss expenses do not materially exceed EUR 2.3 billion, per Hannover Rück.

That target gives the November report a clear numerical benchmark. The company must deliver at least EUR 1.3 billion more net income after the EUR 1.4 billion reported for the first half of 2026, a comparison that places the remaining earnings burden in view.

Q2 profit supports the target

In Q2 2026, Hannover Rück reported EUR 7.157 billion in revenue, EUR 695.3 million in net income and diluted earnings per share of EUR 5.77, according to IT Boltwise in its report on September 25, 2026. The Q2 result accounts for 25.8 percent of the minimum full-year net income target, using the reported quarterly figure against the company target.

The central risk is the major-loss budget. Hannover Rück's guidance links earnings delivery directly to claims from large events, so the next report will show whether the first nine months kept that variable within the company's stated framework.

Consensus points above the price

The published analyst consensus is Buy from 15 analysts, with 7 Buy ratings, 7 Holds and 1 Sell. The average target is EUR 280.60, which lies 10.4 percent above the EUR 254.20 Xetra price, while the target range runs from EUR 246 to EUR 330, according to Investing.com on October 2, 2026.

Stock remains below yearly high

Hannover Rück's current price is EUR 27.00 below its 52-week high of EUR 281.20 and EUR 30.80 above its 52-week low of EUR 223.40, both as of October 5, 2026. Its market capitalization was EUR 30.7 billion and trading volume was 44,268 shares on the same date.

Key facts on Hannover Rück stock

  • Company: Hannover Rück SE
  • ISIN: DE0008402215
  • WKN: 840221
  • Ticker: HNR1
  • Trading venue: Xetra
  • Price (as of October 5, 2026, 3:53 p.m. CEST): EUR 254.20
  • Market capitalization: EUR 30.7 billion (as of October 5, 2026)
  • 52-week range: EUR 223.40-EUR 281.20 (as of October 5, 2026)
  • Sector / Industry: Insurance / Reinsurance
  • Index membership: DAX

Upcoming dates for Hannover Rück stock

  • November 9, 2026: Publication of the quarterly statement for the period to September 30

More news and analyses on Hannover Rück stock

Disclaimer...

en | DE0008402215 | HANNOVER RüCK | boerse | 70233860 | bgmi